ClinicalTrials.Veeva

Menu

N-acetyl-cysteine and Carbohydrate Metabolism Disorder in Obese Women

P

Poznan University of Life Sciences

Status

Unknown

Conditions

Carbohydrate Metabolism Disorder
Insulin Resistance
Obesity

Treatments

Dietary Supplement: NAC group
Dietary Supplement: Control group

Study type

Interventional

Funder types

Other

Identifiers

NCT03902327
PoznanULS

Details and patient eligibility

About

The effect of N-acetylcysteine supplementation on carbohydrate metabolism disorder and homocysteine concentrations in obese women will be analysed.

Enrollment

30 estimated patients

Sex

Female

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • women diagnosed with carbohydrate metabolism disorder,
  • obesity (BMI >29,9 kg/m2)
  • patients not participating in other similar research programs at the same time,
  • written agreement to take part in the research.

Exclusion criteria

  • the use of medicament that may affect on carbohydrate metabolism within 4 weeks,
  • failure to comply with dietary recommendations established during the nutritional intervention,
  • pregnancy and breast feeding.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

30 participants in 2 patient groups

NAC group
Experimental group
Description:
NAC for 12 weeks, 1.6 mg/day, 4x400 mg; a diet based on general recommendations for people with carbohydrate metabolism disorder
Treatment:
Dietary Supplement: NAC group
Control group
Active Comparator group
Description:
Placebo for 12 weeks and a diet based on general recommendations for people with carbohydrate metabolism disorder
Treatment:
Dietary Supplement: Control group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems